L. Wucherpfennig

Reproducibility of pulmonary magnetic resonance angiography in adults with muco-obstructive pulmonary disease

H. Kauczor, R. Eberhardt, C. Heussel, 2022, Acta radiologica.

Iterative Metal Artifact Reduction (iMAR) of the Non-adhesive Liquid Embolic Agent Onyx in Computed Tomography

M. Bendszus, C. Weyland, M. Möhlenbruch, 2021, Clinical Neuroradiology.

Hyperthermia affects collagen fiber architecture and induces apoptosis in pancreatic and fibroblast tumor hetero-spheroids in vitro.

I. Hilger, U. Teichgraeber, A. Berndt, 2020, Nanomedicine : nanotechnology, biology, and medicine.

Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis.

H. Kauczor, O. Sommerburg, C. Heussel, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Visibility of liquid embolic agents in fluoroscopy: a systematic in vitro study

M. Bendszus, C. Weyland, M. Möhlenbruch, 2022, Journal of neurointerventional surgery.

The impact of software-based metal artifact reduction on the liquid embolic agent Onyx in cone-beam CT: a systematic in vitro and in vivo study

M. Bendszus, C. Weyland, M. Möhlenbruch, 2021, Journal of NeuroInterventional Surgery.

Metal artifacts and artifact reduction of neurovascular coils in photon-counting detector CT versus energy-integrating detector CT — in vitro comparison of a standard brain imaging protocol

H. Kauczor, H. Schlemmer, S. Sawall, 2022, European Radiology.

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging

H. Kauczor, I. Baumann, O. Sommerburg, 2023, Frontiers in Pharmacology.